Introduction to placebo effects in medicine: Mechanisms and clinical implications

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 366, Issue 1572, 2011, Pages 1783-1789

  Meissner, Karin ^a,b   Kohls, Niko ^a,c,d   Colloca, Luana ^e,f  

^a UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Peter Schilffarth Institute for Sociotechnology   (Germany)

^d SAMUELI INSTITUTE   (United States)

^e National Center for Alternative and Complementary Medicine (NCCAM)   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Clinical practice; Neurobiology; Nocebo; Placebo; Psychological mechanisms; Randomized controlled trials

Indexed keywords

DRUG; HEALTH CARE; LEARNING; NEUROLOGY; PSYCHOLOGY;

ARTICLE; CLINICAL TRIAL (TOPIC); HUMAN; METHODOLOGY; PHYSIOLOGICAL STRESS; PLACEBO EFFECT; PSYCHOSOMATICS;

CLINICAL TRIALS AS TOPIC; HUMANS; PLACEBO EFFECT; PSYCHOSOMATIC MEDICINE; RESEARCH DESIGN; STRESS, PHYSIOLOGICAL;

EID: 79956354000     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2010.0414     Document Type: Article

References (64)

1. Beecher, H. K. 1956 Relationship of significance of wound to pain experienced. J. Am. Med. Assoc. 161, 1609-1613. (doi:10.1001/jama.1956.02970170005002)
2. Beecher, H. K. 1955 The powerful placebo. J. Am. Med. Assoc. 159, 1602-1606.
3. Kienle, G. S. & Kiene, H. 1997 The powerful placebo effect: fact or fiction? J. Clin. Epidemiol. 50, 1311-1318. (doi:10.1016/S0895-4356(97)00203-5)
4. Levine, J. D., Gordon, N. C. & Fields, H. L. 1978 The mechanism of placebo analgesia. Lancet 2, 654-657. (doi:10.1016/S0140-6736(78)92762-9)
5. Levine, J. D. & Gordon, N. C. 1984 Influence of the method of drug administration on analgesic response. Nature 312, 755-756. (doi:10.1038/312755a0)
6. Benedetti, F. 1996 The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 64, 535-543. (doi:10.1016/0304-3959(95)00179-4)
7. Benedetti, F., Amanzio, M. & Maggi, G. 1995 Potentiation of placebo analgesia by proglumide. Lancet 346, 1231. (doi:10.1016/S0140-6736(95)92938-X)
8. Amanzio, M. & Benedetti, F. 1999 Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J. Neurosci. 19, 484-494.
9. Gracely, R. H., Dubner, R., Wolskee, P. J. & Deeter, W. R. 1983 Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature 306, 264-265. (doi:10. 1038/306264a0)
10. Grevert, P., Albert, L. H. & Goldstein, A. 1983 Partial antagonism of placebo analgesia by naloxone. Pain 16, 129-143. (doi:10.1016/0304-3959(83)90203-8)
11. Posner, J. & Burke, C. A. 1985 The effects of naloxone on opiate and placebo analgesia in healthy volunteers. Psychopharmacology 87, 468-472. (doi:10.1007/BF00432515)
12. Petrovic, P., Kalso, E., Petersson, K. M. & Ingvar, M. 2002 Placebo and opioid analgesia-imaging a shared neuronal network. Science 295, 1737-1740. (doi:10. 1126/science.1067176)
13. Zubieta, J. K., Bueller, J. A., Jackson, L. R., Scott, D. J., Xu, Y., Koeppe, R. A., Nichols, T. E. & Stohler, C. S. 2005 Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J. Neurosci. 25, 7754-7762. (doi:10.1523/JNEUROSCI.0439-05.2005)
14. Eippert, F., Bingel, U., Schoell, E. D., Yacubian, J., Klinger, R., Lorenz, J. & Buchel, C. 2009 Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63, 533-543. (doi:10.1016/j.neuron.2009.07.014)
15. Tracey, I. 2010 Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat. Med. 16, 1277-1283. (doi:10.1038/nm.2229)
16. Colloca, L., Lopiano, L., Lanotte, M. & Benedetti, F. 2004 Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol. 3, 679-684. (doi:10.1016/S1474-4422(04)00908-1)
17. Rodriguez-Raecke, R., Doganci, B., Breimhorst, M., Stankewitz, A., Buchel, C., Birklein, F. & May, A. 2010 Insular cortex activity is associated with effects of negative expectation on nociceptive long-term habituation. J. Neurosci. 30, 11363-11368. (doi:10. 1523/JNEUROSCI.2197-10.2010)
18. Benedetti, F., Amanzio, M. & Thoen, W. 2010 Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors. Psychopharmacology 213, 791-797. (doi:10.1007/s00213-010-2037-y)
19. Benedetti, F., Amanzio, M., Casadio, C., Oliaro, A. & Maggi, G. 1997 Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain 71, 135-140. (doi:10.1016/S0304-3959(97)03346-0)
20. de la Fuente-Fernandez, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B. & Stoessl, A. J. 2001 Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293, 1164-1166. (doi:10.1126/science.1060937)
21. Benedetti, F., Colloca, L., Torre, E., Lanotte, M., Melcarne, A., Pesare, M., Bergamasco, B. & Lopiano, L. 2004 Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat. Neurosci. 7, 587-588. (doi:10.1038/nn1250)
22. Meissner, K. 2011 The placebo effect and the autonomic nervous system: evidence for an intimate relationship. Phil. Trans. R. Soc. B 366, 1808-1817. (doi:10.1098/rstb.2010.0403)
23. Schedlowski, M. & Pacheco-Lopez, G. 2010 The learned immune response: Pavlov and beyond. Brain Behav. Immunol. 24, 176-185. (doi:10.1016/j.bbi.2009.08.007)
24. Vits, S., Cesko, E., Enck, P., Hillen, U., Schadendorf, D. & Schedlowski, M. 2011 Behavioral conditioning as the mediator of placebo responses in the immune system. Phil. Trans. R. Soc. B 366, 1799-1807. (doi:10.1098/rstb.2010.0392)
25. Wolf, S. 1950 Effects of suggestion and conditioning on the action of chemical agents in human subjects; the pharmacology of placebos. J. Clin. Invest. 29, 100-109. (doi:10.1172/JCI102225)
26. Kirsch, I. 1999 Hypnosis and placebos: response expectancy as a mediator of suggestion effects. Anal. Psicología 15, 99-110.
27. Colloca, L. & Miller, F. G. 2011 How placebo responses are formed: a learning perspective. Phil. Trans. R. Soc. B 366, 1859-1869. (doi:10.1098/rstb.2010.0398)
28. Pollo, A., Carlino, E. & Benedetti, F. 2011 Placebo mechanisms across different conditions: from the clinical setting to physical performance. Phil. Trans. R. Soc. B 366, 1790-1798. (doi:10.1098/rstb.2010.0381)
29. Flaten, M. A., Aslaksen, P. M., Lyby, P. S. & Bjørkedal, E. 2011 The relation of emotions to placebo responses. Phil. Trans. R. Soc. B 366, 1818-1827. (doi:10.1098/rstb.2010.0407)
30. Colloca, L. & Miller, F. G. 2011 Harnessing the placebo effect: the need for translational research. Phil. Trans. R. Soc. B 366, 1922-1930. (doi:10.1098/rstb.2010.0399)
31. Colloca, L. & Benedetti, F. 2009 Placebo analgesia induced by social observational learning. Pain 144, 28-34. (doi:10.1016/j.pain.2009.01.033)
32. Hyland, M. E. 2011 Motivation and placebos: do different mechanisms occur in different contexts? Phil. Trans. R. Soc. B 366, 1828-1837. (doi:10.1098/rstb.2010.0391)
33. Kaptchuk, T. J. 2011 Placebo studies and ritual theory: a comparative analysis of Navajo, acupuncture and biomedical healing. Phil. Trans. R. Soc. B 366, 1849-1858. (doi:10.1098/rstb.2010.0385)
34. Shapiro, A. K. & Morris, L. A. 1978 The placebo effect in medical and psychological therapies. In Handbook of psychotherapy and behaviour change (eds S. L. Garfield & A. E. Bergin), pp. 369-410. New York, NY: John Wiley.
35. Schweinhardt, P., Seminowicz, D. A., Jaeger, E., Duncan, G. H. & Bushnell, M. C. 2009 The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. J. Neurosci. 29, 4882-4887. (doi:10.1523/JNEUROSCI. 5634-08.2009)
36. Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A. & Zubieta, J. K. 2008 Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch. Gen. Psychiatry 65, 220-231. (doi:10.1001/archgenpsychiatry.2007.34)
37. Mackenbach, J. P. 2005 On the survival of the altruistic trait in medicine: is there a link with the placebo effect? J. Clin. Epidemiol. 58, 433-435. (doi:10.1016/j.jclinepi.2004.09.007)
38. Geers, A. L., Wellman, J. A., Fowler, S. L., Helfer, S.G. & France, C. R. 2010 Dispositional optimism predicts placebo analgesia. J. Pain 11, 1165-1171. (doi:10.1016/j.jpain.2010.02.014)
39. Geers, A. L., Helfer, S. G., Kosbab, K., Weiland, P. E. & Landry, S. J. 2005 Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response. J. Psychosom. Res. 58, 121-127. (doi:10.1016/j.jpsychores.2004.08.011)
40. Morton, D. L., Watson, A., El-Deredy, W. & Jones, A. K. 2009 Reproducibility of placebo analgesia: effect of dispositional optimism. Pain 146, 194-198. (doi:10.1016/j.pain.2009.07.026)
41. Kohls, N., Sauer, S., Offenbächer, M. & Giordano, J. 2011 Spirituality: an overlooked predictor of placebo effects? Phil. Trans. R. Soc. B 366, 1838-1848. (doi:10.1098/rstb.2010.0389)
42. Enck, P., Klosterhalfen, S., Weimer, K., Horing, B. & Zipfel, S. 2011 The placebo response in clinical trials: more questions than answers. Phil. Trans. R. Soc. B 366, 1889-1895. (doi:10.1098/rstb.2010.0384)
43. Shedden Mora, M., Nestoriuc, Y. & Rief, W. 2011 Lessons learned from placebo groups in antidepressant trials. Phil. Trans. R. Soc. B 366, 1879-1888. (doi:10.1098/rstb.2010.0394)
44. Walach, H. 2011 Placebo controls: historical, methodological and general aspects. Phil. Trans. R. Soc. B 366, 1870-1878. (doi:10.1098/rstb.2010.0401)
45. Papakostas, G. I. & Fava, M. 2009 Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur. Neuropsychopharmacol. 19, 34-40. (doi:10.1016/j.euroneuro.2008.08.009)
46. Sinyor, M., Levitt, A. J., Cheung, A. H., Schaffer, A., Kiss, A., Dowlati, Y. & Lanctot, K. L. 2010 Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. J. Clin. Psychiatry 71, 270-279. (doi:10.4088/JCP.08r04516blu)
47. Diener, H. C., Dowson, A. J., Ferrari, M., Nappi, G. & Tfelt-Hansen, P. 1999 Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials. Cephalalgia 19, 699-700. (doi:10.1046/j.1468-2982.1999.019008699.x)
48. Mallinckrodt, C. H., Zhang, L., Prucka, W. R. & Millen, B. A. 2010 Signal detection and placebo response in schizophrenia: parallels with depression. Psychopharmacol. Bull 43, 53-72.
49. Klosterhalfen, S., Vase, L. & Enck, P. 2010 The likelihood of receiving the drug determines the size of the placebo response. Neurogastroenterol. Motil 22, 1-22. (doi:10.1111/j.1365-2982.2010.01548.x)
50. Moncrieff, J., Wessely, S. & Hardy, R. 2004 Active placebos versus antidepressants for depression. Cochrane Database Syst. Rev. 1, CD003012. (doi:10.1002/14651858.CD003012.pub2)
51. Hrobjartsson, A. & Gotzsche, P. C. 2010 Placebo interventions for all clinical conditions. Cochrane Database Syst. Rev. 1, CD003974. (doi:10.1002/14651858.CD003974.pub3)
52. Linde, K., Niemann, K. & Meissner, K. 2010 Are sham acupuncture interventions more effective than (other) placebos? A re-analysis of data from the Cochrane review on placebo effects. Forsch Komplementmed 17, 259-264. (doi:10.1159/000320374)
53. Linde, K., Niemann, K., Schneider, A. & Meissner, K. 2010 How large are the nonspecific effects of acupuncture? A meta-analysis of randomized controlled trials. BMC Med. 8, 75. (doi:10.1186/1741-7015-8-75)
54. Kaptchuk, T. J. et al. 2006 Sham device v inert pill: randomized controlled trial of two placebo treatments. BMJ 332, 391-397. (doi:10.1136/bmj.38726.603310.55)
55. Scharf, H. P., Mansmann, U., Streitberger, K., Witte, S., Kramer, J., Maier, C., Trampisch, H. J. & Victor, N. 2006 Acupuncture and knee osteoarthritis: a three armed randomized trial. Ann. Intern. Med. 145, 12-20.
56. Haake, M., Muller, H. H., Schade-Brittinger, C., Basler, H. D., Schafer, H., Maier, C., Endres, H. G., Trampisch, H. J. & Molsberger, A. 2007 German Acupuncture Trials (GERAC) for chronic low back pain: randomized, multi center, blinded, parallel-group trial with 3 groups. Arch. Intern. Med. 167, 1892-1898. (doi:10.1001/archinte.167.17.1892)
57. Linde, K., Fässler, M. & Meissner, K. 2011 Placebo interventions, placebo effects and clinical practice. Phil. Trans. R. Soc. B 366, 1905-1912. (doi:10.1098/rstb.2010.0383)
58. Jonas, W. B. 2011 Reframing placebo in research and practice. Phil. Trans. R. Soc. B 366, 1896-1904. (doi:10.1098/rstb.2010.0405)
59. Montgomery, G. & Kirsch, I. 1996. Mechanisms of placebo pain reduction: an empirical investigation. Psychol. Sci. 7, 174-176. (doi:10.1111/j.1467-9280.1996.tb00352.x)
60. Benedetti, F., Arduino, C. & Amanzio, M. 1999 Somatotopic activation of opioid systems by target-directed expectations of analgesia. J. Neurosci. 19, 3639-3648.
61. Meissner, K. 2009 Effects of placebo interventions on gastric motility and general autonomic activity. J. Psychosom. Res. 66, 391-398. (doi:10.1016/j.jpsychores.2008.09.004)
62. Wachholtz, A. B. & Pargament, K. I. 2005 Is spirituality a critical ingredient of meditation? Comparing the effects of spiritual meditation, secular meditation, and relaxation on spiritual, psychological, cardiac, and pain outcomes. J. Behav. Med. 28, 369-384. (doi:10.1007/s10865-005-9008-5)
63. Giordano, J. & Kohls, N. 2008 Spirituality, suffering, and the self. Mind Matter 6, 179-191.
64. Vase, L., Nørskov, K. N., Petersen, G. L. & Price, D. D. 2011 Patients' direct experiences as central elements of placebo analgesia. Phil. Trans. R. Soc. B 366, 1913-1921. (doi:10.1098/rstb.2010.0402)